Updated on 16 October 2026
Oncolipsy Products: CE-IVD Advanced Solutions for Oncology
Senior IVD Development and Technology Transfer Officer/ Responsible for Regulatory Compliance at Pharmassist Ltd/Oncolipsy
Athens, Greece
About
Oncolipsy is a cutting-edge product line designed to support oncology diagnostics through advanced CE-IVD Real-Time PCR-based technologies. Focused on liquid biopsy applications, our solutions enable the sensitive and specific detection of cancer-associated biomarkers.
The current portfolio includes the Oncolipsy PD-L1 kit and the Oncolipsy PIK3CA kit, designed to support key applications in molecular oncology and treatment monitoring.
Developed under high-quality standards and CE-IVD compliance, Oncolipsy products provide laboratories and diagnostic providers with reliable tools for molecular analysis, supporting patient monitoring and personalized treatment strategies. Our technologies are further protected by granted patents in key global markets, including Europe, the USA, Canada, Israel, India, China, Japan, and Hong Kong, reinforcing the innovation and global potential of the platform.
We aim to collaborate with oncology clinics, hospitals, diagnostic laboratories, and distributors to expand access to innovative oncology and liquid biopsy solutions through marketplace platforms and strategic partnerships.
Similar opportunities
Project cooperation
Molecular Diagnostics & Histopathology Joint Research
- Strategic Partner
- Writing project proposal
- Technological contribution
Sittia Basil hassan ali
Lab Technologist at Al rahma
Doha, Qatar
Product
Reagents and Intermediate Products for IVD Manufacturing & R&D
- Other
- Buyer
- Re-Seller/Wholesaler
- BIOLOGY / BIOTECHNOLOGY
- INDUSTRIAL BIOTECHNOLOGY
Benoît Autem
CEO at D-tek
Mons, Belgium
Service
- LIFE SCIENCE
- Research & Development
- BIOLOGY / BIOTECHNOLOGY
- MICRO- AND NANOTECHNOLOGY
Gijs Dingemans
CEO at TuataraDx
Helmond, Netherlands